News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kruse Bo
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/19/2023 |
4
| Kruse Bo (EVP, CFO, Secry & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 11,700 shares
@ $0
Granted 70,100 options to buy
@ $4.7, valued at
$329.5k
|
|
| 04/28/2022 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $9.51, valued at
$713.3k
|
|
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2022 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $9.84, valued at
$39.4k
|
|
| 01/05/2022 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $17.12, valued at
$68.5k
|
|
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $18.09, valued at
$72.4k
|
|
| 11/05/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $27.54, valued at
$110.2k
|
|
| 10/26/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $25.94, valued at
$103.8k
|
|
| 10/05/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $28.78, valued at
$115.1k
|
|
| 09/23/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $30.82, valued at
$123.3k
|
|
| 09/08/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $32.03, valued at
$128.1k
|
|
| 08/24/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $28.6, valued at
$114.4k
|
|
| 08/05/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $33.72, valued at
$134.9k
|
|
| 07/07/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $34.15, valued at
$136.6k
|
|
| 06/23/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $36.17, valued at
$144.7k
|
|
| 06/07/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $33.48, valued at
$133.9k
|
|
| 05/26/2021 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $35.61, valued at
$142.4k
|
|
| 12/16/2020 |
4
| Kruse Bo (EVP, CFO, Secy & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 72,350 options to buy
@ $53.88, valued at
$3.9M
|
|
| 05/15/2020 |
4
| Kruse Bo (EVP, CFO, Secy & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 14,724 shares
@ $37.8645, valued at
$557.5k
Sold 19,230 shares
@ $37.8783, valued at
$728.4k
Sold 28,199 shares
@ $36.0251, valued at
$1M
Sold 37,847 shares
@ $36.0275, valued at
$1.4M
|
|
| 01/09/2020 |
4
| Kruse Bo (EVP, CFO, Secy & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $30.34, valued at
$3.9M
|
|
| 12/13/2018 |
4
| Kruse Bo (EVP, CFO, Secy & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 107,500 options to buy
@ $21.97, valued at
$2.4M
|
|
| 09/20/2018 |
3
| Kruse Bo (EVP, CFO, Secy & Treas.) has filed a Form 3 on Y-mAbs Therapeutics, Inc. |
|
|